The Castleman Disease Collaborative Network (CDCN) was co-founded in 2012 by Dr. David Fajgenbaum and Dr. Frits van Rhee (of the University of Arkansas for Medical Sciences). The goal from the start was to accelerate research to find a cure for Castleman disease (CD) and improve survival for all patients with CD. Drs. Fajgenbaum and van Rhee quickly brought together a global team of other physicians, researchers, patients, and loved ones, and their collaboration has made tremendous progress over the last five years.
The Castleman Disease Collaborative Network (CDCN) is a global initiative dedicated to accelerating research and treatment for Castleman disease (CD) to improve survival for all patients with CD. We work to achieve this by facilitating collaboration among the global research community, mobilizing resources, strategically investing in high-impact research, and supporting patients and their loved ones.
CD describes a group of inflammatory disorders that vary from a single enlarged lymph node to life-threatening multiple organ failure. CD is diagnosed in approximately 6,500 to 7,700 patients of all ages each year in the U.S.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Philadelphia, Pa 19104, Us
- Industry
- Research
- Website
- castlemannetwork.org
- HQ
- Philadelphia, PA
- Competitors
- Reagan-Udall Foundation for the FDA, American Association for Cancer Research, Creyon Bio, University of Pennsylvania Perelman School of Medicine, Every Cure, Recordati Rare Diseases North America, Cure., National Organization for Rare Disorders, Medidata Solutions, Sofitel Philadelphia at Rittenhouse Square.
Castleman Disease Collaborative Network Questions
Castleman Disease Collaborative Network's website is castlemannetwork.org
Castleman Disease Collaborative Network's LinkedIn profile is https://www.linkedin.com/company/castleman-disease-collaborative-network
Castleman Disease Collaborative Network has
7 employees.
View email and phone details for 7
employees at Castleman Disease Collaborative Network.
Castleman Disease Collaborative Network's industry is
Research
Castleman Disease Collaborative Network's top competitors are
Reagan-Udall Foundation For The Fda,
American Association For Cancer Research,
Creyon Bio,
University Of Pennsylvania Perelman School Of Medicine,
Every Cure,
Recordati Rare Diseases North America,
Cure.,
National Organization For Rare Disorders,
Medidata Solutions,
Sofitel Philadelphia At Rittenhouse Square.
Castleman Disease Collaborative Network's categories are Research
Castleman Disease Collaborative Network's founding year is 2012
